Purdue Pharma has launched an awareness campaign to address specific knowledge gaps among pharmacists related to its Schedule III extended-release transdermal opioid, Butrans.
Big Belli on Thursday announced the December 2014 premiere of a documentary called “40 Weeks.”
The Food and Drug Administration has granted approval to Esbriet (pirfenidone), as well as Ofev (nintedanib), to treat idiopathic pulmonary fibrosis — a condition in which the lungs scar over time.
Specialty pharmacy Burmans last week received the new “Shaping Healthcare Delivery” award at this year’s AmerisourceBergen’s ThinkLive Conference.
As the Food and Drug Administration begins to explore ways to improve its user-fee program for generic drugs, the Generic Pharmaceutical Association and its members have weighed in with suggestions on how to shore up the law to ensure that it helps bring generics to market faster and provides benefits across the entire healthcare system.
Could the regulatory and scientific logjam that’s keeping copycat biotech medicines off the market and out of the hands of patients and health providers in the United States finally be breaking?
What’s in a name? A lot, apparently, if the name applies to a biosimilar medicine.
The adoption of personal medical devices and healthcare kiosks that capture consumer health data — like blood pressure and glucose — coupled with data points with a patient’s health record at the pharmacy represents a significant opportunity to enhance disease state management programs.
AbbVie has notified Shire of its board of directors' intention to reconsider the recommendation made on July 18 that AbbVie stockholders adopt the merger agreement needed to complete the proposed combination of AbbVie and Shire.
The U.S. Supreme Court on Wednesday heard arguments from Teva Pharmaceutical Industries in defense of the patent protecting its $4 billion multiple sclerosis drug Copaxone, according to a Reuters report.